Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MINT-IMATINIB DIN 02492342

Status: Marketed
Holder: MINT PHARMACEUTICALS INC
Molecule: IMATINIB (IMATINIB MESYLATE)
Available to quote

Health Canada record

Active ingredient(s)IMATINIB (IMATINIB MESYLATE) 400 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCL01EA01 IMATINIB
Original market date19-Jun-2020
Current status date19-Jun-2020
SourceHealth Canada DPD

Establishment licence of the holder

Mint Pharmaceuticals Inc — licence 101613, currently licensed, last inspection rating C (2023-01-16).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing IMATINIB (IMATINIB MESYLATE)

DINProductCompanyFormStrengthStatus
02490986ACH-IMATINIBACCORD HEALTHCARE INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02490994ACH-IMATINIBACCORD HEALTHCARE INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02355337APO-IMATINIBAPOTEX INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02355345APO-IMATINIBAPOTEX INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02253275GLEEVECNOVARTIS PHARMACEUTICALS CANADA INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02253283GLEEVECNOVARTIS PHARMACEUTICALS CANADA INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02521210IMATINIBSIVEM PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02504596IMATINIBSANIS HEALTH INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02504618IMATINIBSANIS HEALTH INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02521202IMATINIBSIVEM PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02492334MINT-IMATINIBMINT PHARMACEUTICALS INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02397293NAT-IMATINIBNATCO PHARMA (CANADA) INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02397285NAT-IMATINIBNATCO PHARMA (CANADA) INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02428318TARO-IMATINIBSUN PHARMA CANADA INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGApproved
02428326TARO-IMATINIBSUN PHARMA CANADA INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGApproved
02399814TEVA-IMATINIBTEVA CANADA LIMITEDTabletIMATINIB (IMATINIB MESYLATE) 400 MGMarketed
02399806TEVA-IMATINIBTEVA CANADA LIMITEDTabletIMATINIB (IMATINIB MESYLATE) 100 MGMarketed
02244725GLEEVECNOVARTIS PHARMACEUTICALS CANADA INCCapsuleIMATINIB (IMATINIB MESYLATE) 100 MGCancelled Post Market
02495066JAMP IMATINIBJAMP PHARMA CORPORATIONTabletIMATINIB (IMATINIB MESYLATE) 100 MGDormant
02495074JAMP IMATINIBJAMP PHARMA CORPORATIONTabletIMATINIB (IMATINIB MESYLATE) 400 MGDormant
02424495MYLAN-IMATINIBMYLAN PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 100 MGCancelled Pre Market
02424509MYLAN-IMATINIBMYLAN PHARMACEUTICALS ULCTabletIMATINIB (IMATINIB MESYLATE) 400 MGCancelled Pre Market
02431122PMS-IMATINIBPHARMASCIENCE INCTabletIMATINIB (IMATINIB MESYLATE) 400 MGDormant
02431114PMS-IMATINIBPHARMASCIENCE INCTabletIMATINIB (IMATINIB MESYLATE) 100 MGDormant
02515547SANDOZ IMATINIBSANDOZ CANADA INCORPORATEDTabletIMATINIB (IMATINIB MESYLATE) 100 MGCancelled Pre Market
02515555SANDOZ IMATINIBSANDOZ CANADA INCORPORATEDTabletIMATINIB (IMATINIB MESYLATE) 400 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
226662019-09-18Abbreviated New Drug Submission (ANDS)
Request a quote for MINT-IMATINIB

How to read a Canadian DIN record